MWNA
ONSIW

Marshall Wace North America’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Marshall Wace North America’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-125,400
Closed -$1K – 1757
2018
Q3 		$1K Hold
125,400
– – ﹤0.01% 885
2018
Q2 		$6K Hold
125,400
– – ﹤0.01% 1341
2018
Q1 		$125K Hold
125,400
– – ﹤0.01% 1364
2017
Q4 		$4K Hold
125,400
– – ﹤0.01% 1334
2017
Q3 		$0 Buy
125,400
+300
+0.2% +$38 ﹤0.01% 1660
2017
Q2 		$0 Hold
125,100
– – ﹤0.01% 1538
2017
Q1 		$125K Buy
+125,100
New +$53K ﹤0.01% 932

Marshall Wace North America's ONSIW Position: Q4 2018 in Review

Marshall Wace North America sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q4 2018, closing a stake of 125,400 shares — an estimated $1K sold.

Marshall Wace North America first reported a position in ONSIW in Q1 2017 and held it in 7 quarters. The position peaked at $125K in Q1 2018. 0 funds tracked by Wall St. Rank hold ONSIW as of Q4 2018.

  • Marshall Wace North America reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q4 2018 after selling out during the quarter.
  • Marshall Wace North America sold 125,400 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q4 2018, an estimated $1K.
  • Marshall Wace North America first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q1 2017 and held it in 7 quarters.
  • Marshall Wace North America's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $125K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q4 2018.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.